Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-745-6 | CAS number: 205041-15-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The potential of N1,N3-diallylpropane-1,3-diamine dihydrochloride to induce skin irritation/corrosion was evaluated in two suitable in vitro test methods (OECD 439 and OECD 431). Based on the results, N1,N3-diallylpropane-1,3- diamine dihydrochloride (100% purity) must be considered as irritant to skin and classification as Skin Irrit. 2, H315 is warranted in accordance with CLP regulation 1272/2008.
In addition, effects on eye irritation were investigated in two in vitro tests according to OECD 437 and OECD 492. Following the combined assessment of the two studies, classification for Eye Irrit. 2, H319 in accordance with CLP Regulation 1272/2008 is warranted.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2020-03-09 to 2020-04-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Version / remarks:
- adopted 18th June 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- 25 mg of the test item were applied directly atop the EpiDerm^TM tissue using an application spoon avoiding compression of the test item. To ensure good contact with the skin the test item was moistened with 25 μL H2O. The volume of H2O was increased, and the test item was spread to match size of the tissue. - Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- The EpiDerm^TM Skin Model is a well-established organotypic, three-dimensional model of the human epidermis and is used for in vitro experiments since many years. It is known for its similarity to human skin.
- Vehicle:
- water
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm(TM), EPI-200 (MatTek)
- Tissue batch number(s): Lot No. 30851 A
EpiDerm Kit:
The EpiDerm tissues were provided as kits (MatTek), consisting of the following components relevant for this study:
1x sealed plate containing e.g. 24 reconstructed epidermis units (area: 0.63 cm²); each reconstructed epidermis is attached to a cell culture insert and maintained on nutritive agar for transport (Lot: 30851 A)
2x 24-well plates
4x 6-well plates
1x bottle of assay medium (DMEM-based medium; Lot: 030520MJC)
1x bottle of DPBS Rinse Solution (Lot: 112719ISE)
25 pieces Nylon Mesh circles (8 mm diameter, 200 µm pore)
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37 ± 1 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: After 3 min or 60 min of application, the inserts were removed from the 6-well plate with forceps. Using a wash bottle, the tissue was gently rinsed about 20 times with PBS (phosphate buffered saline) to remove any residual test item.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: MTT stock solution (5 mg/mL) was diluted 1 + 4 with DMEM-based medium (final concentration 1 mg/mL)
- Incubation time: 3 h
- Wavelength: 570 nm
NUMBER OF REPLICATE TISSUES: 2
PREDICTION MODEL / DECISION CRITERIA: For more details see Table 1 in section "Any other information on materials and methods incl. tables"
See Table 1 in box "Any other information on materials and methods incl. tables". - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied: 25 mg + 50 μL H2O (the volume was increased to spread the test item on the surface of the tissue)
VEHICLE : water
- Amount(s) applied: 50 µl
NEGATIVE CONTROL : distilled water
- Amount(s) applied: 50 μL
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 50 μL 8 N KOH
- Concentration (if solution): 8 N - Duration of treatment / exposure:
- 3 min and 60 min
- Duration of post-treatment incubation (if applicable):
- 3 h
- Number of replicates:
- 2
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3 min exposure period, mean of replicates
- Value:
- 107.4
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: non-corrosive
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 60 min exposure period, mean of replicates
- Value:
- 68.1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: non-corrosive
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Direct-MTT reduction: The mixture of 25 mg test item per 1 mL MTT medium showed no reduction of MTT as compared to the solvent. The mixture did not turn blue/purple. Therefore, NSMTT is determined to be 0%.
- Colour interference with MTT: The mixture of 25 mg test item per 300 μL Aqua dest. and 300 µL isopropanol showed no colouring as compared to the solvent. Therefore NSC is determined to be 0%.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative & positive control: The controls confirmed the validity of the study. The mean OD570nm of the two negative control tissues was ≥ 0.8 and ≤ 2.8 for each exposure period (1.687, 1.823). The mean relative tissue viability (% negative control) of the positive control was < 15% (3.4%) after 60 min treatment. The coefficient of variation (CV) (in the range of 20 – 100% viability) of replicate tissues of all dose groups was ≤ 30% (0.3% - 6.4%).
For details and raw data results please refer to Tables 2 and 3 in section "Any other information on results incl. tables". - Interpretation of results:
- other: non-corrosive
- Conclusions:
- In this study under the given conditions the test item showed no corrosive effects. The mean relative tissue viability (% negative control) was above 15% after 60 min treatment and above 50% after 3 min treatment. Therefore, the test item is classified as “non-corrosive“.
- Executive summary:
In a primary skin corrosion study conducted according to OECD guideline 431, two EpiDerm tissues per exposure time were exposed to 25 mg of N1,N3 -diallylpropane-1,3 -diamine dihydrochloride (100% purity) for 60 min and 3 min. Cytotoxicity was measured in comparison to the concurrent negative controls via the MTT reduction assay and irritation was scored by the method of mean relative tissue viability. The test item showed no corrosive effects. The mean relative tissue viability (% negative control) was ≥15% (68.1%) after 60 min treatment and ≥50% (107.4%) after 3 min treatment. The controls confirmed the validity of the study and all acceptance criteria were fulfilled.
Based on the results from this study, the test item can be classified as non-corrosive. To specify the classification in accordance to CLP regulation 1272/2008 the results from an OECD 439 study must be additionally consulted.
The study is acceptable and satisfies the guideline requirements for an in vitro skin corrosion study (OECD 431).
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2020-04-20 to 2020-05-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- adopted 18th June 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- TREATMENT OF TEST MATERIAL PRIOR TO TESTING
Firstly, 25 μL of sterile DPBS were applied to the epidermal surface in order to improve the contact between the powder and the epidermis. Afterwards, 25 mg (39 mg/cm²) of the test item were applied directly atop the EpiDerm(^TM) tissue using an application spoon avoiding compression of the test item. The test item was spread to match size of the tissue by using a bulb-headed Pasteur pipette.
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- This test uses the EpiDerm™ reconstructed human epidermis model (MatTek) which consists of normal human epidermal keratinocytes (NHEK) and therefore represents in vitro the target organ of the species of interest and closely mimics the biochemical and physiological properties of the upper parts of the human skin, i.e. the epidermis.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™-Standard Model (EPI-200-SIT, MatTek)
- Tissue batch number(s): Lot No.: 30858
EpiDerm Kit:
The EpiDerm™ tissues were provided as kits (e.g. EPI-200-SIT, MatTek), consisting of the following components relevant for this study:
1x sealed 24-well plate containing e.g. 24 reconstructed epidermis units (area: 0.63 cm²); each reconstructed epidermis is attached to a cell culture insert and maintained on nutritive agar for transport (Lot No.: 25864)
2x 24-well plates
8x 6-well plates
1x bottle of assay medium (DMEM-based medium, Lot No.: 041620MJD)
1x bottle of DPBS Rinse Solution (Lot No.:012120MJA)
1x 1 vial 5% SDS Solution (TC-SDS-5%)
25 pieces Nylon Mesh circles (8 mm diameter, 200 μm pore)
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature for 25 min, 35 min at 37 ± 1 °C
- Temperature of post-treatment incubation (if applicable): 37 ± 1 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: After dosing of all tissues, all plates were incubated for 25 ± 1 min under the sterile flow and for the remaining time of 35 ± 1 min transferred to the incubator.Then, the tissues were washed by filling and emptying the inserts 15 times with DPBS using a constant stream in about 1.5 cm distance from the tissue surface. Subsequently, the inserts were completely submerged three times in 150 mL DPBS and shaken to remove rests of the test item. Finally, the inserts were rinsed once from the inside and the outside with sterile DPBS.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: MTT stock solution (5 mg/mL) was diluted 1 + 4 with DMEM-based medium (final concentration 1 mg/mL)
- Incubation time: 3 h ± 5 min
- Spectrophotometer: yes
- Wavelength: 570 nm
- Filter bandwidth: ± 30 nm
NUMBER OF REPLICATE TISSUES: three
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if viability after 1 hour exposure is less than 50% relative to the negative control.
- The test substance is considered to be non-irritant to skin if the viability after 1 hour exposure is greater than 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied: 25 mg (39 mg/cm²) + 25 µL DPBS
NEGATIVE CONTROL : Dulbecco’s phosphate buffered saline (DPBS)
- Amount(s) applied (volume or weight): 30 µl
POSITIVE CONTROL : Sodium dodecyl sulfate (SDS)
- Amount(s) applied (volume or weight): 30 µl
- Concentration (if solution): 5% - Duration of treatment / exposure:
- 60 min (25 ± 1 min under the sterile flow and for the remaining time of 35 ± 1 min transferred to the incubator)
- Duration of post-treatment incubation (if applicable):
- 42 h post-incubation
- Number of replicates:
- three per treatment group
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- mean of triplicates
- Value:
- 2.9
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Direct-MTT reduction: no
- Colour interference with MTT: no
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, OD570 nm ≥ 0.8 and ≤ 2.8 (1.945)
- Acceptance criteria met for positive control: yes, mean relative tissue viability of the three positive control tissues is ≤ 20% (3.7%)
- Acceptance criteria met for variability between replicate measurements: yes, standard deviation (SD) of relative tissue viability obtained from each three concurrently tested tissues is ≤ 18%. (0.1-7.1%)
For detailed results see Table 1 in box "Any other information on results incl tables". - Interpretation of results:
- Category 2 (irritant) based on GHS criteria
- Conclusions:
- In this in vitro skin irritation study (OECD 439), the test item is considered to be irritant to the skin. In combination with the results from an OECD 431 test, it can be concluded, that classification as skin irritant (Category 2) is warranted.
- Executive summary:
In a primary dermal irritation study conducted according to OECD guideline 439, the EpiDerm™-Model (EPI-200-SIT) was topically exposed to N1,N3-diallypropane-1,3-diamine dihydrochloride (100% purity) for 60 min and 42 h post incubation period. Irritant potential of the test item was predicted from the relative mean tissue viabilities obtained compared to the corresponding negative control tissues concurrently treated with DPBS. The mean relative tissue viability (% negative control) was ≤ 50% (2.9%). The controls confirmed the validity of the study and all acceptance criteria were fulfilled. Based on this result N1,N3-diallypropane-1,3-diamine dihydrochloride is considered to be irritating to the skin. In combination with the results from a second in vitro test (OECD 431), it can be concluded that classification as Skin Irrit. 2, H315 is warranted.
The study is acceptable and satisfies the guideline requirements for an in vitro skin irritation study (OECD 439).
Referenceopen allclose all
Table 2: Results of 3 min Experiment
Name |
Negative Control |
Positive Control |
Test Item |
|||
Replicate Tissue |
1 |
2 |
1 |
2 |
1 |
2 |
Absolute OD570 |
1.673 |
1.716 |
0.120 |
0.109 |
1.908 |
1.755 |
1.654 |
1.683 |
0.120 |
0.108 |
1.872 |
1.714 |
|
1.725 |
1.674 |
0.120 |
0.110 |
1.882 |
1.719 |
|
Mean Absolute OD570 |
1.687*** |
0.114 |
1.808 |
|||
OD570- Blank Corrected |
1.623 |
1.666 |
0.070 |
0.059 |
1.858 |
1.705 |
1.604 |
1.633 |
0.070 |
0.058 |
1.822 |
1.664 |
|
1.675 |
1.624 |
0.070 |
0.060 |
1.832 |
1.669 |
|
Mean OD570of 3 Aliquots (Blank Corrected) |
1.634 |
1.641 |
0.070 |
0.059 |
1.838 |
1.679 |
SD OD570 of 3 Aliquots |
0.037 |
0.022 |
0.000 |
0.001 |
0.019 |
0.022 |
Total Mean OD570of 2 Replicate Tissues (Blank Corrected) |
1.637* |
0.064 |
1.758 |
|||
SD OD570 of 2 Replicate Tissues |
0.005 |
0.008 |
0.112 |
|||
Mean Relative Tissue |
100.0 |
3.9 |
107.4 |
|||
Coefficient Of Variation [%]** |
0.3 |
12.1 |
6.4 |
*corrected mean OD570of the negative control corresponds to 100% absolute tissue viability.
**coefficient of variation (CV) (in the range of 20 – 100% viability) between two tissues treated identically is ≤ 30%.
***The mean absolute OD570of the negative control is ≥ 0.8 and ≤ 2.8
Table 3: Results of 60 min Experiment
Name |
Negative Control |
Positive Control |
Test Item |
|||
Replicate Tissue |
1 |
2 |
1 |
2 |
1 |
2 |
Absolute OD570 |
1.886 |
1.821 |
0.103 |
0.122 |
1.305 |
1.276 |
1.765 |
1.868 |
0.103 |
0.116 |
1.279 |
1.194 |
|
1.772 |
1.829 |
0.100 |
0.118 |
1.281 |
1.210 |
|
Mean Absolute OD570 |
1.823**** |
0.110 |
1.257 |
|||
OD570- Blank Corrected |
1.836 |
1.771 |
0.053 |
0.072 |
1.255 |
1.226 |
1.715 |
1.818 |
0.053 |
0.066 |
1.229 |
1.144 |
|
1.722 |
1.779 |
0.050 |
0.068 |
1.231 |
1.160 |
|
Mean OD570of 3 Aliquots (Blank Corrected) |
1.757 |
1.789 |
0.052 |
0.069 |
1.238 |
1.177 |
SD OD570 of 3 Aliquots |
0.068 |
0.025 |
0.001 |
0.003 |
0.015 |
0.043 |
Total Mean OD570of 2 Replicate Tissues (Blank Corrected) |
1.773* |
0.060 |
1.207 |
|||
SD OD570 of 2 Replicate Tissues |
0.023 |
0.012 |
0.044 |
|||
Mean Relative Tissue |
100.0 |
3.4** |
68.1 |
|||
Coefficient Of Variation [%]*** |
1.3 |
19.7 |
3.6 |
*corrected mean OD570of the negative control corresponds to 100% absolute tissue viability.
**mean relative tissue viability of the 60 min positive control is ≤ 15%,
***coefficient of variation (CV) (in the range of 20 – 100% viability) between two tissues treated identically is ≤ 30%.
****The mean absolute OD570of the negative control is ≥ 0.8 and ≤ 2.8
Table 1: Result of the Test Item N1,N3-diallylpropane-1,3-diamine dihydrochloride
Name | Negative Control | Positive Control | Test Item | ||||||
Replicate Tissue | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
Absolute OD570 | 1.961 | 1.837 | 2.108 | 0.119 | 0.119 | 0.115 | 0.105 | 0.104 | 0.106 |
1.913 | 1.79 | 2.06 | 0.116 | 0.122 | 0.122 | 0.105 | 0.101 | 0.103 | |
Mean Absolute OD570 | 1.945**** | 0.119 | 0.104 | ||||||
OD570 (Blank Corrected) | 1.913 | 1.789 | 2.06 | 0.071 | 0.07 | 0.067 | 0.057 | 0.056 | 0.058 |
1.865 | 1.742 | 2.012 | 0.067 | 0.074 | 0.074 | 0.057 | 0.053 | 0.055 | |
Mean OD570 of the Duplicates (Blank Corrected) | 1.889 | 1.766 | 2.036 | 0.069 | 0.072 | 0.07 | 0.057 | 0.055 | 0.056 |
Total Mean OD570 of the 3 Replicate Tissues (Blank Corrected) | 1.897* | 0.071 | 0.056 | ||||||
SD of Mean OD570 of the 3 Replicate Tissues (Blank Corrected) | 0.135 | 0.002 | 0.001 | ||||||
Relative Tissue Viability [%] | 99.6 | 93.1 | 107.3 | 3.6 | 3.8 | 3.7 | 3 | 2.9 | 3 |
Mean Relative Tissue Viability [%] | 100 | 3.7** | 2.9 | ||||||
SD of Relative Tissue Viability [%]*** | 7.1 | 0.1 | 0.1 | ||||||
CV [% Viabilities] | 7.1 | 2.2 | 2.1 | ||||||
* Blank-corrected mean OD570 of the negative control corresponds to 100% absolute tissue viability. | |||||||||
** Mean relative tissue viability of the three positive control tissues is ≤ 20%. | |||||||||
*** Standard deviation (SD) obtained from the three concurrently tested tissues is ≤ 18%. | |||||||||
**** The mean absolute OD570 of the negative control is ≥ 0.8 and ≤ 2.8. |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2020-04-21 to 2020-05-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Version / remarks:
- adopted 09th October 2017
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test item was tested as supplied. - Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
Corneas of calves aged les than 8 months were collected in the slaughterhouse of Sobeval Boulazac 24759 - France, in a short time after slaughtering of the animals and transported in a Hanks´s buffered saline solution with antibiotic to the laboratory. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied: 750 ± 75 mg - Duration of treatment / exposure:
- 4 hours at 32 +/- 1 °C
- Duration of post- treatment incubation (in vitro):
- The permeability at 490 nm was measured upon 90 minutes of incubation with fluorescein after exposure to the test item by using a spectrophotometer.
- Number of animals or in vitro replicates:
- Three corneas each for the test item, negative control and positive control.
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAS
- At reception, calve eyes were carefully examined under lighting and these showing a visble defect were eliminated. For each selected eye, an incision with a scalpel was practiced at the level of the scleral ring by means of scissors. Approximately 2 to 3 mm of scleral ring were left to facilitate the further handlings. Corneas were immersed in Hanks' medium at room temperature. For mounting, the corneas were deposited, endothelial side upwards on the posterior part of cornea holders. Then the anterior part was firmly clamped in place with 3 screws. The anteroir (epithelial side) and posterior (endothelial side) compartments were then filled with pre-warmed EMEM without phenol and ensuring that no bubbles were formed. The corneas were incubated for one hour at 32 +/- 1 °C.
INITIAL OPACITY and CORNEA SELECTION
- After pre-incubation, compartments were emptied and fresh EMEM was added. The opacity at t=0 (OPT0) was then determined. Corneas showing a value of opacity greater than seven opacity units were discarded.
NUMBER OF REPLICATES
- 3 corneas for test item, 3 corneas for negative control and 3 corneas for the positive control
NEGATIVE CONTROL USED
- 0.9% NaCl, Cooper batch 13NLP271
POSITIVE CONTROL USED
- Imidazole, diluted at 20% with 0.9% NaCl, Sigma batch: SLBTZ469
APPLICATION DOSE AND EXPOSURE TIME :
- 750 ± 75 mg for 4 hours
TREATMENT METHOD: open chamber
REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: After the end of the exposure period, the test item and controls were removed from the anterior compartment and the epithelium washed at least three times (or until no visual evidence of test item can be observed) with EMEM containing phenol red. After the last effective rinsing, corneas were given a final rinse with EMEM without phenol red, what allowed to make sure that the inside of support was cleared of any phenol red before the next measure of opacity.
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Opacity was determined by the amount of light transmission through the cornea. Corneal opacity was measured quantitatively with the aid of an opacitometer (OP-KIT), resulting in opacity values measured on a continuous scale. The opacity of each cornea was measured at 2 times, just before treatment with the test item (OPT0) and immediately after the end of the exposure period (OPT2)
- Corneal permeability: Passage of sodium fluorescein dye measured with the aid of a spectrophotometer (software VISION lite(TM) version 2.2) (OD490) . The assessment of this parameter was performed after the 2nd opacity measurement.
- Other: Corneas were observed and visible modifications of the cornea (oedema, colouring) were noted.
SCORING SYSTEM: In Vitro Irritancy Score (IVIS) (mean opacity value + (15 x mean permeability OD490 value))
DECISION CRITERIA: The decision criteria as indicated in the TG were used (see Table 1 in box "Any other information on materials and methods incl. tables). - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- mean of triplicates
- Value:
- 10.7
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: no prediction can be made
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: epithelium detachment
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, the test was considered acceptable if the negative control gave opacity values OP < 12 and the optical density OD < 0.140. They were respectively: OP = 0.7 and OD = 0.004.
- Acceptance criteria met for positive control: yes, the test was considered acceptable if the positive control gives an IVIS that ranged within two standard deviations of the current historical mean (80.3 < IVIS < 179.3) (Result: 133.2 ± 12.0). - Interpretation of results:
- other: No prediction can be made
- Conclusions:
- In conclusion, based on the mean in vitro irritation score of 10.7 obtained in the bovine corneal opacity and permeability assay (BCOP, OECD 437), no prediction can be made regarding the classification of the test substance.
- Executive summary:
The eye irritation potential of N1,N3-diallypropane-1,3-diamine dihydrochloride (100% purity) was investigated in the bovine corneal opacity and permeability assay (BCOP, OECD 437). A mean in vitro irritation score of 10.7 was determined. The positive and negative controls induced the appropriate responses, indicating the validity of the assay. Based on the results obtained, no prediction can be made regarding the classification of the substance.
The study is acceptable and satisfies the guideline requirements for an in vitro study for eye damage (OECD 437).
Reference
Table 2: Results of the main experiment
4 h treatment | ||||||||
Support Nos | Treatment | Opt0 | Opt2 | Opt2-Opt0 | adjusted opacity | OD | OD adjusted | Score (Opa+15xODa) |
26 | Negative control NaCl 0.9%, | 2 | 3 | 1 | 0 | 0 | 0 | |
7 | 4 | 2 | -2 | 0.006 | 0.006 | 0.1 | ||
18 | 0 | 3 | 3 | 0.007 | 0.007 | 0.1 | ||
Observations: - | Mean | 0.7 | 0.004 | 0.004 | 0.1 | |||
SD | 2.5 | 0.004 | 0.004 | 0.1 | ||||
Support Nos | Treatment | Opt0 | Opt2 | Opt2-Opt0 | adjusted opacity |
OD | OD adjusted |
Score (Opa+15xODa) |
4 | Positive control Imidazol | 0 | 90 | 90 | 89.3 | 2.418 | 2.414 | 125.5 |
27 | 0 | 115 | 115 | 114.3 | 2.186 | 2.182 | 147.1 | |
15 | 0 | 90 | 90 | 89.3 | 2.51 | 2.506 | 126.9 | |
Observations:Oedema and high epithelium detachment | Mean | 97.7 | 2.367 | 133.2 | ||||
SD | 14.4 | 0.167 | 12 | |||||
Support Nos | Treatment | Opt0 | Opt2 | Opt2-Opt0 | adjusted opacity | OD | OD adjusted | Score (Opa+15xODa) |
22 | N1,N3-diallylpropane-1,3-diamine dihydrochloride | 0 | 11 | 11 | 10.3 | 0.066 | 0.062 | 11.3 |
13 | 0 | 14 | 14 | 13.3 | 0.158 | 0.154 | 15.6 | |
12 | 2 | 6 | 4 | 3.3 | 0.125 | 0.121 | 5.1 | |
Observations:Epithelium detachment |
Mean | 9 | 0.112 | 10.7 | ||||
SD | 5.1 | 0.047 | 5.3 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In a primary skin corrosion study conducted according to OECD guideline 431, two EpiDerm tissues per exposure time were exposed to 25 mg of N1,N3-diallylpropane-1,3-diamine dihydrochloride (100% purity) for 60 min and 3 min. Cytotoxicity was measured in comparison to the concurrent negative controls via the MTT reduction assay and irritation was scored by the method of mean relative tissue viability. The test item showed no corrosive effects. The mean relative tissue viability (% negative control) was ≥15% (68.1%) after 60 min treatment and ≥50% (107.4%) after 3 min treatment. The controls confirmed the validity of the study and all acceptance criteria were fulfilled.
Based on the results from this study, the test item can be classified as non-corrosive. To specify the classification in accordance to CLP regulation 1272/2008 the results from an OECD 439 study must be additionally consulted.
In the study conducted according to OECD guideline 439, the EpiDerm™-Model (EPI-200-SIT) was topically exposed to N1,N3-diallypropane-1,3-diamine dihydrochloride (100% purity) for 60 min and 42 h post incubation period. Irritant potential of the test item was predicted from the relative mean tissue viabilities obtained compared to the corresponding negative control tissues concurrently treated with DPBS. The mean relative tissue viability (% negative control) was ≤ 50% (2.9%). The controls confirmed the validity of the study and all acceptance criteria were fulfilled. Based on this result N1,N3-diallypropane-1,3-diamine dihydrochloride is considered to be irritating to the skin. In combination with the results from a second in vitro test (OECD 431), it can be concluded that classification as Skin Irrit. 2, H315 is warranted.
The eye irritation potential of N1,N3-diallylpropane-1,3-diamine dihydrochloride (100% purity) was investigated in two in vitro eye irritation studies. In the bovine corneal opacity and permeability assay (BCOP, OECD TG 437) a mean in vitro irritation score of 10.7 was determined. The positive and negative controls induced the appropriate responses, indicating the validity of the assay. Based on the results, the conditions for classification for serious eye damage were not fulfilled. But, also the conditions to justify a non-classification were not fulfilled and no prediction on classification can be made by this test alone.
In the second in vitro eye irritation test, conducted according to OECD TG 492, the test item showed irritant effects (mean tissue viability 2.6% compared to negative control). Based on the results, the conditions for non-classification were not fulfilled. No prediction of the classification can be made since from this study alone it cannot be differentiated between UN GHS “Category 1” or “Category 2”, if the relative tissue viability is less or equal to 60%.
Based on the available data and assessing them in a weight-of-evidence approach, classification for serious eye irritation (Eye Irrit. 2, H319) is warranted in accordance with the CLP Regulation 1272/2008.
Justification for classification or non-classification
Based on the available data and assessing them in a weight-of-evidence approach, classification for serious eye and skin irritation (Eye Irrit. 2, H319; Skin Irrit. 2, H315) is warranted in accordance with the CLP Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.